[{"Assets_0_Q2_USD":85216000.0,"CommonStockSharesOutstanding_0_Q2_shares":1490950.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20599000.0,"NetIncomeLoss_2_Q2_USD":-17008000.0,"NetIncomeLoss_1_Q2_USD":-8946000.0,"StockholdersEquity_0_Q2_USD":-71655000.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170811"}]